phenyl acetate has been researched along with Apolipoprotein B-100, Familial Defective in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiyer, A; Asp, P; Barahman, M; Beck, AP; Guha, C; Harris, HY; Kabarriti, R; Kinkhabwala, M; Roy-Chowdhury, J; Roy-Chowdhury, N; Scanlan, TS; Zhang, W | 1 |
Heinonen, T; Klepack, E; Lovalvo, J; Marais, AD; McLain, R; Raal, FJ | 1 |
Knight, BL; Patel, DD; Soutar, AK | 2 |
Büchner, SA | 1 |
Knight, BL; Patel, DD; Pullinger, CR | 1 |
Miettinen, TA | 1 |
Manack, L; Skolnick, AA | 1 |
Muth, J; Shireman, RB; Toth, JP | 1 |
Avigan, J; Beg, ZH; Reznikov, DC | 1 |
Amorosa, LF; Islam, MA; Khachadurian, AK; Yamin, TT | 1 |
1 trial(s) available for phenyl acetate and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia.
Topics: Acetamides; Acetates; Administration, Oral; Adolescent; Adult; Age Factors; Atorvastatin; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Multivariate Analysis; Probability; Pyrroles; Reference Values; Risk Assessment; Severity of Illness Index; Sex Factors; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Sulfonamides; Sulfonic Acids; Treatment Outcome | 2003 |
10 other study(ies) available for phenyl acetate and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis.
Topics: Acetates; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Dyslipidemias; Female; Hepatocytes; Hyperlipoproteinemia Type II; Male; Mice; Mice, Inbred C57BL; Phenols | 2019 |
The regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity, cholesterol esterification and the expression of low-density lipoprotein receptors in cultured monocyte-derived macrophages.
Topics: Acetates; Acetic Acid; Blood Proteins; Cells, Cultured; Cholesterol; Esterification; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, LDL; Macrophages; Monocytes; Receptors, Cell Surface; Receptors, LDL | 1983 |
[Chemosurgical treatment of xanthelasmas with Solcoderm].
Topics: Acetates; Acetic Acid; Antineoplastic Combined Chemotherapy Protocols; Copper; Dermatologic Agents; Eyelid Diseases; Female; Humans; Hyperlipoproteinemia Type II; Lactates; Male; Nitrates; Wound Healing; Xanthomatosis | 1984 |
The absolute rate of cholesterol biosynthesis in monocyte-macrophages from normal and familial hypercholesterolaemic subjects.
Topics: Acetates; Acetic Acid; Cells, Cultured; Cholesterol; Desmosterol; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Macrophages; Monocytes; Proteins; Triparanol | 1984 |
Effects of neomycin alone and in combination with cholestyramine on serum methyl sterols and conversion of acetate and mevalonate to cholesterol.
Topics: Acetates; Cholesterol; Cholestyramine Resin; Feces; Humans; Hyperlipoproteinemia Type II; Mevalonic Acid; Neomycin; Steroids; Sterols | 1982 |
Science reporters hear wide range of recent data at 12th annual conference.
Topics: Acetates; Aged; AIDS Vaccines; American Medical Association; Amines; Animals; Anticonvulsants; beta-Cyclodextrins; Cells, Cultured; Clinical Trials as Topic; Cochlear Implants; Complementary Therapies; Constriction, Pathologic; Coronary Artery Bypass; Cyclodextrins; Cyclohexanecarboxylic Acids; Depressive Disorder; Drug Therapy, Combination; Epilepsy; Extracorporeal Membrane Oxygenation; Felbamate; Fetus; Gabapentin; gamma-Aminobutyric Acid; Genetic Therapy; Health Care Costs; HIV Infections; Humans; Hyperlipoproteinemia Type II; Lamotrigine; Muscle, Smooth; National Institutes of Health (U.S.); Oxygen; Phenylcarbamates; Propylene Glycols; Respiration, Artificial; Respiratory Distress Syndrome; Triazines; United States; Vascular Surgical Procedures | 1993 |
[14C]acetate incorporation by cultured normal, familial hypercholesterolemia and Down's syndrome fibroblasts.
Topics: Acetates; Acetic Acid; Carbon Radioisotopes; Cells, Cultured; Cholesterol; Down Syndrome; Fibroblasts; Gas Chromatography-Mass Spectrometry; Humans; Hyperlipoproteinemia Type II; Insulin; Leucine; Protein Biosynthesis; Receptors, LDL; Selenium; Transferrin | 1988 |
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone.
Topics: Acetates; AMP-Activated Protein Kinases; Cells, Cultured; Fibroblasts; Fluorides; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Ketocholesterols; Lipid Metabolism; Lipoproteins, LDL; Mevalonic Acid; Multienzyme Complexes; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Complex; Sterols; Water | 1986 |
Stimulation of cholesterol and lipid synthesis by insulin in familial hypercholesterolemic fibroblasts.
Topics: Acetates; Cells, Cultured; Cholesterol; Fatty Acids; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Insulin; Lipids; Phospholipids | 1986 |
Regulation of synthesis and cell content of the low-density-lipoprotein receptor protein in cultured fibroblasts from normal and familial hypercholesterolaemic subjects.
Topics: Acetates; Cell Membrane; Cells, Cultured; Cholesterol; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Immunochemistry; Lipoproteins; Lovastatin; Methionine; Naphthalenes; Radioimmunoassay; Receptors, LDL | 1987 |